Mia's Feed
Medical News & Research

Efficacy of Home-Based Hypertension Management in Rural South Africa

Efficacy of Home-Based Hypertension Management in Rural South Africa

Share this article

A groundbreaking study shows that home-based, technology-supported hypertension management significantly improves blood pressure control in rural South African communities, offering a scalable solution to bridge healthcare gaps.

2 min read

Recent research presented at the ESC Congress 2025 and published in the New England Journal of Medicine highlights the promising impact of home-based hypertension care in rural South Africa. Hypertension, a leading risk factor for stroke and cardiovascular diseases in South Africa, remains poorly controlled despite the availability of affordable treatments. Barriers such as lack of patient confidence, overcrowded clinics, long waiting times, and transportation costs hinder effective management.

The IMPACT-BP trial, conducted at the Africa Health Research Institute in KwaZulu-Natal, investigated whether technology-supported home interventions could improve blood pressure control. The trial recruited 774 adults with uncontrolled hypertension, defined by systolic BP >140 mmHg and/or diastolic BP >90 mmHg, with participants randomized into three groups:

  1. Standard clinic-based hypertension management.
  2. Home-based BP self-monitoring assisted by community health workers, who performed home visits for data collection and medication delivery, with remote nurse-led care supported by a mobile app.
  3. An enhanced community health worker group using cellular technology to transmit BP readings automatically to a mobile application.

The study's primary measure was the change in systolic blood pressure over six months. Results showed significant reductions in systolic BP in both home-based groups compared to standard care. The community health worker group saw an average decrease of 7.9 mmHg, while the enhanced group experienced an even greater reduction of 9.1 mmHg. Hypertension control rates improved from 57.6% with usual care to over 80% with home-based interventions. Notably, these gains persisted at the 12-month mark.

Importantly, the intervention groups maintained high retention rates (>95%) and reported positive experiences with self-managing their condition. Severe adverse events and deaths were rare and similar across all groups, indicating safety.

Experts emphasized that shifting chronic disease management from the clinic to the patient's home can significantly improve outcomes, especially in underserved communities. The success of this model demonstrates that equitable healthcare access and effective hypertension control are achievable in resource-limited rural settings. Future efforts may expand such programs to include management of multiple conditions and address additional structural barriers.

This study underscores the potential for innovative, patient-centered approaches to tackle hypertension and reduce cardiovascular risk in disadvantaged, remote communities.

Source: https://medicalxpress.com/news/2025-09-home-based-hypertension-effective-rural.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Concerns Over the Potential Loss of a Massive Veterans' DNA Database and Its Impact on Medical Research

Over one million veterans contributed DNA samples to a vital health research database, but recent uncertainties threaten its future, risking setbacks in understanding and treating veteran-related health issues.

Critical Gaps in Genetic Cancer Risk Testing Revealed by Recent Study

A study uncovers significant gaps in genetic testing for Lynch syndrome among womb cancer patients, highlighting the need for improved screening processes to prevent future cancers and protect families.

Innovative Needle-Free, Live-Attenuated Influenza Vaccines Offer Broad Protection

Discover breakthrough needle-free, live-attenuated influenza vaccines developed by Hong Kong researchers that offer broad protection against multiple virus subtypes, including potential pandemic strains.